TRF— 510(k) K983167

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K983167 for TRF, Substantially Equivalent on 1998-11-04. Applicant: Abbott Laboratories. Device class: 2.

Clearance details

Applicant: Abbott Laboratories
Product code: Code DDG
Device class: Class 2
Regulation: 21 CFR 866.5880
Advisory panel: Immunology
Date received: 1998-09-10
Decision date: 1998-11-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irving, TX, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DDG

K240987 — Access sTfR2024-07-03
K190495 — Transferrin2020-03-16
K182095 — Tina-quant Transferrin ver.2 (urine application)2018-11-05
K120236 — TRANSFERRIN KIT FOR USE ON THE SPAPLUS2013-02-13
K080634 — ACCESS STFR, ACCESS STFR CALIBRATORS, AND ACCESS STFR QC WITH MODELS, A32493, A32494, AND A324952008-08-11

More clearances from Abbott Laboratories

K252424 — Anti-HCV Next2026-04-28
K243500 — ARCHITECT iGentamicin2025-07-09
K243168 — Alinity i Rubella IgG2025-06-20
K243283 — Alinity h-series System2025-02-20
K233932 — Alinity i Toxo IgM2024-08-30

Recalls naming K983167

K-number listed on FDA's recall record

Z-1995-2019 — Transferrin is an in vitro diagnostic assay for the quantitative determination of transferrin in human serum or plasma. Antigen in the sample bonds to the specific antibody in the reagent, forming an immune complex. The immune complex causes an increase in light scattering, measured by reading turbidity at 700 nm, which correlates with the concentration of transferrin in the sample.Class II·Terminated·Abbott Laboratories, Inc·20180516

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K983167.

Data sourced from openFDA. This site is unofficial and independent of the FDA.